vs

Side-by-side financial comparison of EXPONENT INC (EXPO) and Waystar Holding Corp. (WAY). Click either name above to swap in a different company.

Waystar Holding Corp. is the larger business by last-quarter revenue ($313.9M vs $166.3M, roughly 1.9× EXPONENT INC). EXPONENT INC runs the higher net margin — 17.8% vs 13.8%, a 4.0% gap on every dollar of revenue. On growth, Waystar Holding Corp. posted the faster year-over-year revenue change (22.4% vs 14.3%). Over the past eight quarters, Waystar Holding Corp.'s revenue compounded faster (15.7% CAGR vs 8.8%).

Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.

Waystar Holding Corp is a leading provider of integrated healthcare payment and revenue cycle management solutions. It serves healthcare providers, health systems, and payers across the United States, offering tools that streamline billing, claims processing, patient payment collection, and revenue optimization to reduce administrative burdens and improve financial performance for healthcare organizations.

EXPO vs WAY — Head-to-Head

Bigger by revenue
WAY
WAY
1.9× larger
WAY
$313.9M
$166.3M
EXPO
Growing faster (revenue YoY)
WAY
WAY
+8.1% gap
WAY
22.4%
14.3%
EXPO
Higher net margin
EXPO
EXPO
4.0% more per $
EXPO
17.8%
13.8%
WAY
Faster 2-yr revenue CAGR
WAY
WAY
Annualised
WAY
15.7%
8.8%
EXPO

Income Statement — Q1 FY2027 vs Q1 FY2026

Metric
EXPO
EXPO
WAY
WAY
Revenue
$166.3M
$313.9M
Net Profit
$29.6M
$43.3M
Gross Margin
Operating Margin
24.9%
25.6%
Net Margin
17.8%
13.8%
Revenue YoY
14.3%
22.4%
Net Profit YoY
11.0%
47.9%
EPS (diluted)
$0.59
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPO
EXPO
WAY
WAY
Q1 26
$166.3M
$313.9M
Q4 25
$147.1M
$303.5M
Q3 25
$142.0M
$268.7M
Q2 25
$145.5M
$270.7M
Q1 25
$136.8M
$256.4M
Q4 24
$244.1M
Q3 24
$136.3M
$240.1M
Q2 24
$140.5M
$234.5M
Net Profit
EXPO
EXPO
WAY
WAY
Q1 26
$29.6M
$43.3M
Q4 25
$28.0M
$20.0M
Q3 25
$26.6M
$30.6M
Q2 25
$26.6M
$32.2M
Q1 25
$23.6M
$29.3M
Q4 24
$19.1M
Q3 24
$26.0M
$5.4M
Q2 24
$29.2M
$-27.7M
Operating Margin
EXPO
EXPO
WAY
WAY
Q1 26
24.9%
25.6%
Q4 25
19.7%
19.4%
Q3 25
12.1%
22.4%
Q2 25
30.5%
24.0%
Q1 25
19.9%
25.4%
Q4 24
21.8%
Q3 24
19.0%
11.3%
Q2 24
25.4%
3.5%
Net Margin
EXPO
EXPO
WAY
WAY
Q1 26
17.8%
13.8%
Q4 25
19.1%
6.6%
Q3 25
18.7%
11.4%
Q2 25
18.3%
11.9%
Q1 25
17.2%
11.4%
Q4 24
7.8%
Q3 24
19.1%
2.3%
Q2 24
20.8%
-11.8%
EPS (diluted)
EXPO
EXPO
WAY
WAY
Q1 26
$0.59
$0.42
Q4 25
$0.55
$0.10
Q3 25
$0.52
$0.17
Q2 25
$0.52
$0.18
Q1 25
$0.45
$0.16
Q4 24
$0.18
Q3 24
$0.50
$0.03
Q2 24
$0.57
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPO
EXPO
WAY
WAY
Cash + ST InvestmentsLiquidity on hand
$118.6M
$34.3M
Total DebtLower is stronger
$13.5M
Stockholders' EquityBook value
$338.3M
$3.9B
Total Assets
$687.4M
$5.8B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPO
EXPO
WAY
WAY
Q1 26
$118.6M
$34.3M
Q4 25
$207.4M
$61.4M
Q3 25
$231.8M
$421.1M
Q2 25
$245.1M
$290.3M
Q1 25
$258.9M
$224.0M
Q4 24
$182.1M
Q3 24
$219.7M
$127.1M
Q2 24
$203.3M
$68.4M
Total Debt
EXPO
EXPO
WAY
WAY
Q1 26
$13.5M
Q4 25
$1.5B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
EXPO
EXPO
WAY
WAY
Q1 26
$338.3M
$3.9B
Q4 25
$402.9M
$3.9B
Q3 25
$427.8M
$3.2B
Q2 25
$441.4M
$3.2B
Q1 25
$421.1M
$3.1B
Q4 24
$3.1B
Q3 24
$410.3M
$3.1B
Q2 24
$393.2M
$2.9B
Total Assets
EXPO
EXPO
WAY
WAY
Q1 26
$687.4M
$5.8B
Q4 25
$761.4M
$5.8B
Q3 25
$759.4M
$4.7B
Q2 25
$763.2M
$4.7B
Q1 25
$777.3M
$4.6B
Q4 24
$4.6B
Q3 24
$744.1M
$4.5B
Q2 24
$709.2M
$4.6B
Debt / Equity
EXPO
EXPO
WAY
WAY
Q1 26
0.00×
Q4 25
0.38×
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPO
EXPO
WAY
WAY
Operating Cash FlowLast quarter
$84.9M
Free Cash FlowOCF − Capex
$90.3M
FCF MarginFCF / Revenue
28.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.96×
TTM Free Cash FlowTrailing 4 quarters
$314.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPO
EXPO
WAY
WAY
Q1 26
$84.9M
Q4 25
$32.7M
$66.6M
Q3 25
$36.2M
$82.0M
Q2 25
$7.3M
$96.8M
Q1 25
$56.1M
$64.2M
Q4 24
Q3 24
$29.7M
$78.8M
Q2 24
$48.3M
$15.4M
Free Cash Flow
EXPO
EXPO
WAY
WAY
Q1 26
$90.3M
Q4 25
$30.0M
$57.2M
Q3 25
$33.9M
$76.2M
Q2 25
$5.5M
$91.0M
Q1 25
$53.5M
$58.8M
Q4 24
Q3 24
$28.0M
$70.2M
Q2 24
$47.2M
$8.6M
FCF Margin
EXPO
EXPO
WAY
WAY
Q1 26
28.8%
Q4 25
20.4%
18.9%
Q3 25
23.9%
28.3%
Q2 25
3.8%
33.6%
Q1 25
39.1%
22.9%
Q4 24
Q3 24
20.5%
29.2%
Q2 24
33.6%
3.7%
Capex Intensity
EXPO
EXPO
WAY
WAY
Q1 26
Q4 25
1.8%
3.1%
Q3 25
1.6%
2.2%
Q2 25
1.2%
2.1%
Q1 25
1.9%
2.1%
Q4 24
Q3 24
1.3%
3.6%
Q2 24
0.8%
2.9%
Cash Conversion
EXPO
EXPO
WAY
WAY
Q1 26
1.96×
Q4 25
1.16×
3.33×
Q3 25
1.36×
2.68×
Q2 25
0.27×
3.01×
Q1 25
2.38×
2.20×
Q4 24
Q3 24
1.14×
14.56×
Q2 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXPO
EXPO

Revenues before reimbursements$151.8M91%
Reimbursements$14.5M9%

WAY
WAY

Subscription$172.2M55%
Volume-based$139.5M44%

Related Comparisons